Literature DB >> 3532854

Fatal disseminated bacillus Calmette-Guerin infection and arrested growth of cutaneous malignant melanoma following intralesional immunotherapy.

S M de la Monte, G M Hutchins.   

Abstract

An 84-year-old man with aggressive cutaneous malignant melanoma, which failed to respond to systemic chemotherapy, was electively treated with intralesional bacillus Calmette-Guerin (BCG) immunotherapy. He died with widespread miliary granulomas, most likely representing disseminated BCG infection. However, at autopsy, the patient was found to have a minimal tumor burden and only a single focus of visceral metastatic malignant melanoma. In view of the clinically documented aggressive nature of this patient's disease, the arrested growth of his tumors is best attributed to the beneficial effect of BCG immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3532854     DOI: 10.1097/00000372-198608000-00010

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  4 in total

Review 1.  Intralesional treatment for advanced melanoma: what's on the horizon?

Authors:  Sanjiv Agarwala
Journal:  Melanoma Manag       Date:  2016-05-25

2.  Hypotension and disseminated intravascular coagulation following intralesional bacillus Calmette-Guérin therapy for locally metastatic melanoma.

Authors:  M H Cohen; R J Elin; B J Cohen
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 3.  Intralesional therapy for advanced melanoma: promise and limitation.

Authors:  Sanjiv S Agarwala
Journal:  Curr Opin Oncol       Date:  2015-03       Impact factor: 3.645

Review 4.  Insights into the Molecular Mechanisms Behind Intralesional Immunotherapies for Advanced Melanoma.

Authors:  Dejan Vidovic; Carman Giacomantonio
Journal:  Cancers (Basel)       Date:  2020-05-22       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.